KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Gross Profit: 2015-2024

Historic Gross Profit for Medpace Holdings (MEDP) over the last 10 years, with Dec 2024 value amounting to $656.3 million.

  • Medpace Holdings' Gross Profit rose 16.53% to $196.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $733.6 million, marking a year-over-year increase of 19.33%. This contributed to the annual value of $656.3 million for FY2024, which is 25.13% up from last year.
  • As of FY2024, Medpace Holdings' Gross Profit stood at $656.3 million, which was up 25.13% from $524.5 million recorded in FY2023.
  • Medpace Holdings' Gross Profit's 5-year high stood at $656.3 million during FY2024, with a 5-year trough of $278.7 million in FY2020.
  • For the 3-year period, Medpace Holdings' Gross Profit averaged around $537.7 million, with its median value being $524.5 million (2023).
  • Data for Medpace Holdings' Gross Profit shows a peak YoY surged of 31.78% (in 2022) over the last 5 years.
  • Medpace Holdings' Gross Profit (Yearly) stood at $278.7 million in 2020, then rose by 17.73% to $328.2 million in 2021, then skyrocketed by 31.78% to $432.4 million in 2022, then rose by 21.29% to $524.5 million in 2023, then increased by 25.13% to $656.3 million in 2024.